메뉴 건너뛰기




Volumn 32, Issue 9, 2013, Pages 1099-1109

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment

Author keywords

angiogenesis; glioblastoma; invasion; mammalian target of rapamycin; regulator of G protein signaling

Indexed keywords

CYTOSTATIC AGENT; LOMUSTINE; RGS4 PROTEIN; TEMSIROLIMUS;

EID: 84874739414     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.137     Document Type: Article
Times cited : (31)

References (50)
  • 1
    • 33749262441 scopus 로고    scopus 로고
    • Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-betadependent HIF-1alpha-mediated induction of CXCL12
    • Tabatabai G, Frank B, Mohle R, Weller M, Wick W. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-betadependent HIF-1alpha-mediated induction of CXCL12. Brain 2006; 129: 2426-2435.
    • (2006) Brain , vol.129 , pp. 2426-2435
    • Tabatabai, G.1    Frank, B.2    Mohle, R.3    Weller, M.4    Wick, W.5
  • 2
    • 0035866813 scopus 로고    scopus 로고
    • Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma
    • Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001; 61: 2744-2750.
    • (2001) Cancer Res , vol.61 , pp. 2744-2750
    • Wild-Bode, C.1    Weller, M.2    Rimner, A.3    Dichgans, J.4    Wick, W.5
  • 3
    • 78651500461 scopus 로고    scopus 로고
    • Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide
    • Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 2010; 97: 377-381.
    • (2010) Radiother Oncol , vol.97 , pp. 377-381
    • Minniti, G.1    Amelio, D.2    Amichetti, M.3    Salvati, M.4    Muni, R.5    Bozzao, A.6
  • 4
    • 60649106195 scopus 로고    scopus 로고
    • Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
    • Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15: 220-231.
    • (2009) Cancer Cell , vol.15 , pp. 220-231
    • Paez-Ribes, M.1    Allen, E.2    Hudock, J.3    Takeda, T.4    Okuyama, H.5    Vinals, F.6
  • 5
    • 34347220473 scopus 로고    scopus 로고
    • Defining the role of mTOR in cancer
    • Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007; 12: 9-22.
    • (2007) Cancer Cell , vol.12 , pp. 9-22
    • Guertin, D.A.1    Sabatini, D.M.2
  • 6
    • 13844312400 scopus 로고    scopus 로고
    • Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
    • Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307: 1098-1101.
    • (2005) Science , vol.307 , pp. 1098-1101
    • Sarbassov, D.D.1    Guertin, D.A.2    Ali, S.M.3    Sabatini, D.M.4
  • 7
    • 7944235758 scopus 로고    scopus 로고
    • Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
    • Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6: 1122-1128.
    • (2004) Nat Cell Biol , vol.6 , pp. 1122-1128
    • Jacinto, E.1    Loewith, R.2    Schmidt, A.3    Lin, S.4    Ruegg, M.A.5    Hall, A.6
  • 10
    • 17944368972 scopus 로고    scopus 로고
    • An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten/- mice
    • Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten/- mice. Proc Natl Acad Sci USA 2001; 98: 10320-10325.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 10320-10325
    • Podsypanina, K.1    Lee, R.T.2    Politis, C.3    Hennessy, I.4    Crane, A.5    Puc, J.6
  • 11
    • 3042823868 scopus 로고    scopus 로고
    • The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
    • Chakravarti A, Zhai G, Suzuki Y, Sarkesh S, Black PM, Muzikansky A et al. The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 2004; 22: 1926-1933.
    • (2004) J Clin Oncol , vol.22 , pp. 1926-1933
    • Chakravarti, A.1    Zhai, G.2    Suzuki, Y.3    Sarkesh, S.4    Black, P.M.5    Muzikansky, A.6
  • 12
    • 33746637660 scopus 로고    scopus 로고
    • Current development of mTOR inhibitors as anticancer agents
    • Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 2006; 5: 671-688.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 671-688
    • Faivre, S.1    Kroemer, G.2    Raymond, E.3
  • 13
    • 33746807790 scopus 로고    scopus 로고
    • Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas
    • Doherty L, Gigas DC, Kesari S, Drappatz J, Kim R, Zimmerman J et al. Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas. Neurology 2006; 67: 156-158.
    • (2006) Neurology , vol.67 , pp. 156-158
    • Doherty, L.1    Gigas, D.C.2    Kesari, S.3    Drappatz, J.4    Kim, R.5    Zimmerman, J.6
  • 14
    • 23944453425 scopus 로고    scopus 로고
    • Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A North Central Cancer Treatment Group Study
    • Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, Boni J et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 2005; 23: 5294-5304.
    • (2005) J Clin Oncol , vol.23 , pp. 5294-5304
    • Galanis, E.1    Buckner, J.C.2    Maurer, M.J.3    Kreisberg, J.I.4    Ballman, K.5    Boni, J.6
  • 16
    • 65349121788 scopus 로고    scopus 로고
    • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-466.
    • (2009) Lancet Oncol , vol.10 , pp. 459-466
    • Stupp, R.1    Hegi, M.E.2    Mason, W.P.3    Van Den Bent, M.J.4    Taphoorn, M.J.5    Janzer, R.C.6
  • 17
    • 34548528069 scopus 로고    scopus 로고
    • Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma
    • Motzer RJ, Hudes GR, Curti BD, McDermott DF, Escudier BJ, Negrier S et al. Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma. J Clin Oncol 2007; 25: 3958-3964.
    • (2007) J Clin Oncol , vol.25 , pp. 3958-3964
    • Motzer, R.J.1    Hudes, G.R.2    Curti, B.D.3    McDermott, D.F.4    Escudier, B.J.5    Negrier, S.6
  • 18
    • 68949102180 scopus 로고    scopus 로고
    • Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma
    • Hess G, Herbrecht R, Romaguera J, Verhoef G, Crump M, Gisselbrecht C et al. Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. J Clin Oncol 2009; 27: 3822-3829.
    • (2009) J Clin Oncol , vol.27 , pp. 3822-3829
    • Hess, G.1    Herbrecht, R.2    Romaguera, J.3    Verhoef, G.4    Crump, M.5    Gisselbrecht, C.6
  • 20
    • 0035866358 scopus 로고    scopus 로고
    • Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/ medulloblastoma models as single agent and in combination chemotherapy
    • Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN et al. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/ medulloblastoma models as single agent and in combination chemotherapy. Cancer Res 2001; 61: 1527-1532.
    • (2001) Cancer Res , vol.61 , pp. 1527-1532
    • Geoerger, B.1    Kerr, K.2    Tang, C.B.3    Fung, K.M.4    Powell, B.5    Sutton, L.N.6
  • 21
    • 0030831934 scopus 로고    scopus 로고
    • Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion
    • Sampson JH, Ashley DM, Archer GE, Fuchs HE, Dranoff G, Hale LP et al. Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion. Neurosurgery 1997; 41: 1365-1372.
    • (1997) Neurosurgery , vol.41 , pp. 1365-1372
    • Sampson, J.H.1    Ashley, D.M.2    Archer, G.E.3    Fuchs, H.E.4    Dranoff, G.5    Hale, L.P.6
  • 22
    • 0037200004 scopus 로고    scopus 로고
    • Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin
    • Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. J Biol Chem 2002; 277: 31423-31429.
    • (2002) J Biol Chem , vol.277 , pp. 31423-31429
    • Park, I.H.1    Bachmann, R.2    Shirazi, H.3    Chen, J.4
  • 23
    • 32944457518 scopus 로고    scopus 로고
    • MTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
    • O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 2006; 66: 1500-1508.
    • (2006) Cancer Res , vol.66 , pp. 1500-1508
    • O'Reilly, K.E.1    Rojo, F.2    She, Q.B.3    Solit, D.4    Mills, G.B.5    Smith, D.6
  • 24
    • 62449266454 scopus 로고    scopus 로고
    • TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): Phospho-Ser2481 is a marker for intact mTOR signaling complex 2
    • Copp J, Manning G, Hunter T. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res 2009; 69: 1821-1827.
    • (2009) Cancer Res , vol.69 , pp. 1821-1827
    • Copp, J.1    Manning, G.2    Hunter, T.3
  • 25
    • 58649092475 scopus 로고    scopus 로고
    • MTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
    • Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 2008; 416: 375-385.
    • (2008) Biochem J , vol.416 , pp. 375-385
    • Garcia-Martinez, J.M.1    Alessi, D.R.2
  • 26
    • 66749132465 scopus 로고    scopus 로고
    • Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway
    • Hu W, Li F, Mahavadi S, Murthy KS. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway. Am J Physiol Cell Physiol 2009; 296: C1310-1320.
    • (2009) Am J Physiol Cell Physiol , vol.296
    • Hu, W.1    Li, F.2    Mahavadi, S.3    Murthy, K.S.4
  • 27
    • 78349245231 scopus 로고    scopus 로고
    • Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks
    • Sarkaria JN, Galanis E, Wu W, Dietz AB, Kaufmann TJ, Gustafson MP et al. Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks. Clin Cancer Res 2010; 16: 5573-5580.
    • (2010) Clin Cancer Res , vol.16 , pp. 5573-5580
    • Sarkaria, J.N.1    Galanis, E.2    Wu, W.3    Dietz, A.B.4    Kaufmann, T.J.5    Gustafson, M.P.6
  • 28
    • 33644820339 scopus 로고    scopus 로고
    • Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
    • Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 157-173.
    • (2006) Cancer Cell , vol.9 , pp. 157-173
    • Phillips, H.S.1    Kharbanda, S.2    Chen, R.3    Forrest, W.F.4    Soriano, R.H.5    Wu, T.D.6
  • 29
    • 67649411967 scopus 로고    scopus 로고
    • Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death
    • Ronellenfitsch MW, Brucker DP, Burger MC, Wolking S, Tritschler F, Rieger J et al. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death. Brain 2009; 132: 1509-1522.
    • (2009) Brain , vol.132 , pp. 1509-1522
    • Ronellenfitsch, M.W.1    Brucker, D.P.2    Burger, M.C.3    Wolking, S.4    Tritschler, F.5    Rieger, J.6
  • 30
    • 36148945617 scopus 로고    scopus 로고
    • R4 RGS proteins: Regulation of G-protein signaling and beyond
    • Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 2007; 116: 473-495.
    • (2007) Pharmacol Ther , vol.116 , pp. 473-495
    • Bansal, G.1    Druey, K.M.2    Xie, Z.3
  • 31
    • 70349473057 scopus 로고    scopus 로고
    • Regulator of G-protein signaling (RGS) proteins in cancer biology
    • Hurst JH, Hooks SB. Regulator of G-protein signaling (RGS) proteins in cancer biology. Biochem Pharmacol 2009; 78: 1289-1297.
    • (2009) Biochem Pharmacol , vol.78 , pp. 1289-1297
    • Hurst, J.H.1    Hooks, S.B.2
  • 32
    • 64849103757 scopus 로고    scopus 로고
    • G protein-coupled receptors stimulation and the control of cell migration
    • Cotton M, Claing A. G protein-coupled receptors stimulation and the control of cell migration. Cell Signal 2009; 21: 1045-1053.
    • (2009) Cell Signal , vol.21 , pp. 1045-1053
    • Cotton, M.1    Claing, A.2
  • 34
    • 67651006540 scopus 로고    scopus 로고
    • Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4
    • Xie Y, Wolff DW, Wei T, Wang B, Deng C, Kirui JK et al. Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res 2009; 69: 5743-5751.
    • (2009) Cancer Res , vol.69 , pp. 5743-5751
    • Xie, Y.1    Wolff, D.W.2    Wei, T.3    Wang, B.4    Deng, C.5    Kirui, J.K.6
  • 35
    • 1542297687 scopus 로고    scopus 로고
    • Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility
    • Tatenhorst L, Senner V, Puttmann S, Paulus W. Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 2004; 63: 210-222.
    • (2004) J Neuropathol Exp Neurol , vol.63 , pp. 210-222
    • Tatenhorst, L.1    Senner, V.2    Puttmann, S.3    Paulus, W.4
  • 37
    • 33745712929 scopus 로고    scopus 로고
    • RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion
    • Ding J, Guzman JN, Tkatch T, Chen S, Goldberg JA, Ebert PJ et al. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci 2006; 9: 832-842.
    • (2006) Nat Neurosci , vol.9 , pp. 832-842
    • Ding, J.1    Guzman, J.N.2    Tkatch, T.3    Chen, S.4    Goldberg, J.A.5    Ebert, P.J.6
  • 39
    • 33748746323 scopus 로고    scopus 로고
    • Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4)
    • Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA. Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry 2004; 60: 534-537.
    • (2004) Biol Psychiatry , vol.60 , pp. 534-537
    • Levitt, P.1    Ebert, P.2    Mirnics, K.3    Nimgaonkar, V.L.4    Lewis, D.A.5
  • 40
    • 77956254304 scopus 로고    scopus 로고
    • Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins
    • Blazer LL, Roman DL, Chung A, Larsen MJ, Greedy BM, Husbands SM et al. Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Mol Pharmacol 2010; 78: 524-533.
    • (2010) Mol Pharmacol , vol.78 , pp. 524-533
    • Blazer, L.L.1    Roman, D.L.2    Chung, A.3    Larsen, M.J.4    Greedy, B.M.5    Husbands, S.M.6
  • 42
    • 79251575938 scopus 로고    scopus 로고
    • Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma
    • Pitter KL, Galban CJ, Galban S, Saeed-Tehrani O, Li F, Charles N et al. Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma. PloS One 2011; 6: e14545.
    • (2011) PloS One , vol.6
    • Pitter, K.L.1    Galban, C.J.2    Galban, S.3    Saeed-Tehrani, O.4    Li, F.5    Charles, N.6
  • 43
    • 52449131427 scopus 로고    scopus 로고
    • PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel
    • Yang L, Clarke MJ, Carlson BL, Mladek AC, Schroeder MA, Decker P et al. PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel. Clin Cancer Res 2008; 14: 3993-4001.
    • (2008) Clin Cancer Res , vol.14 , pp. 3993-4001
    • Yang, L.1    Clarke, M.J.2    Carlson, B.L.3    Mladek, A.C.4    Schroeder, M.A.5    Decker, P.6
  • 45
    • 50849095153 scopus 로고    scopus 로고
    • Enzastaurininduced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL
    • Rieger J, Lemke D, Maurer G, Weiler M, Frank B, Tabatabai G et al. Enzastaurininduced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL. J Neurochem 2008; 106: 2436-2448.
    • (2008) J Neurochem , vol.106 , pp. 2436-2448
    • Rieger, J.1    Lemke, D.2    Maurer, G.3    Weiler, M.4    Frank, B.5    Tabatabai, G.6
  • 46
    • 4544341015 scopus 로고    scopus 로고
    • Linear models and empirical bayes methods for assessing differential expression in microarray experiments
    • Article3
    • Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:Article3.
    • (2004) Stat Appl Genet Mol Biol , vol.3
    • Smyth, G.K.1
  • 47
    • 0036081355 scopus 로고    scopus 로고
    • Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
    • Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207-210.
    • (2002) Nucleic Acids Res , vol.30 , pp. 207-210
    • Edgar, R.1    Domrachev, M.2    Lash, A.E.3
  • 48
    • 65649089411 scopus 로고    scopus 로고
    • Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3- dioxygenase-1 via interferon-beta and protein kinase R
    • Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Koppel A et al. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3- dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 2009; 27: 909-919.
    • (2009) Stem Cells , vol.27 , pp. 909-919
    • Opitz, C.A.1    Litzenburger, U.M.2    Lutz, C.3    Lanz, T.V.4    Tritschler, I.5    Koppel, A.6
  • 49
    • 33745197969 scopus 로고    scopus 로고
    • BCL-xL: Timedependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells
    • Weiler M, Bahr O, Hohlweg U, Naumann U, Rieger J, Huang H et al. BCL-xL: timedependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells. Cell Death Differ 2006; 13: 1156-1169.
    • (2006) Cell Death Differ , vol.13 , pp. 1156-1169
    • Weiler, M.1    Bahr, O.2    Hohlweg, U.3    Naumann, U.4    Rieger, J.5    Huang, H.6
  • 50
    • 77951625266 scopus 로고    scopus 로고
    • Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group
    • Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010; 28: 1963-1972.
    • (2010) J Clin Oncol , vol.28 , pp. 1963-1972
    • Wen, P.Y.1    Macdonald, D.R.2    Reardon, D.A.3    Cloughesy, T.F.4    Sorensen, A.G.5    Galanis, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.